Aurinia Pharmaceuticals AUPH Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's inventories?
- Aurinia Pharmaceuticals (AUPH) reported inventories of $46.41M in Q1 2026.
- How has Aurinia Pharmaceuticals's inventories changed year-over-year?
- Aurinia Pharmaceuticals's inventories increased by 0.5% year-over-year, from $46.2M to $46.41M.
- What is the long-term trend for Aurinia Pharmaceuticals's inventories?
- Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's inventories has grown at a 26.3% compound annual growth rate (CAGR), from $71.93M to $183.18M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.